Zhencui Li
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Endocrinology top 5%
- Escherichia coli research studies
- Vibrio bacteria research studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 2
- COVID-19 Clinical Research Studies 2
-
- Antibiotic Resistance in Bacteria 3
- Co-authors
- Youjun Feng (5 shared papers)Rongsui Gao (3 shared papers)Huiyan Ye (3 shared papers)Jingxia Lin (2 shared papers)Qingjing Wang (2 shared papers)Fei Liu (1 shared paper)Yongfei Hu (1 shared paper)Baoli Zhu (1 shared paper)
- Journals
- China CDC Weekly (3 papers)BMC Microbiology (1 paper)Molecular Microbiology (1 paper)Oncotarget (1 paper)PLoS Pathogens (1 paper)
- Partner nations
- ChinaLithuaniaUnited States
In The Last Decade
Zhencui Li
11 papers receiving 443 citations
Peers
Comparison fields: 5 of 56
- Molecular Medicine 307
- Endocrinology 98
- Pollution 106
- Applied Microbiology and Biotechnology 11
- Pharmacology 61
Countries citing papers authored by Zhencui Li
This map shows the geographic impact of Zhencui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhencui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhencui Li more than expected).
Fields of papers citing papers by Zhencui Li
This network shows the impact of papers produced by Zhencui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhencui Li. The network helps show where Zhencui Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhencui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 218 | |
| 2 | 2016 | 108 | |
| 3 | 2014 | 37 | |
| 4 | 2016 | 30 | |
| 5 | 2021 | 23 | |
| 6 | 2016 | 14 | |
| 7 | 2025 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2021 | 1 |
About Zhencui Li
Zhencui Li is a scholar working on Infectious Diseases, Molecular Medicine, Molecular Biology, Pharmacology and Animal Science and Zoology, having authored 12 papers that have together received 446 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Antibiotic Resistance in Bacteria (3 papers), SARS-CoV-2 detection and testing (2 papers), Biotin and Related Studies (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), COVID-19 Clinical Research Studies (2 papers), Animal Virus Infections Studies (2 papers) and Pharmaceutical and Antibiotic Environmental Impacts (1 paper). The work is most often cited by research in Molecular Medicine (307 citations), Endocrinology (98 citations), Pollution (106 citations), Applied Microbiology and Biotechnology (11 citations) and Pharmacology (61 citations). Zhencui Li has collaborated with scholars based in China, Lithuania and United States. Frequent co-authors include Youjun Feng, Rongsui Gao, Huiyan Ye, Jingxia Lin, Qingjing Wang, Fei Liu, Yongfei Hu, Baoli Zhu, De‐Feng Li and Yahong Liu. Their work appears in journals such as China CDC Weekly, BMC Microbiology, Molecular Microbiology, Oncotarget and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.